Physician profile
Patrick Arnold Conway
NPI 1487688594
$8,561.83
in general payments reported to CMS, 2019-2025
37 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $1,385 · 2021: $882 · 2022: $1,505 · 2023: $1,218 · 2024: $926 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,363 · Education: $39.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,362.69 |
| Education | $39.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,832.62 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,138.33 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $790.69 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $742.66 | 2020-2025 | Qulipta, Ubrelvy |
| Sanofi-Aventis U.S. LLC | $564.81 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $468.53 | 2021-2024 | |
| Glaxosmithkline, LLC. | $363.39 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.81 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $289.45 | 2019-2020 | |
| Pfizer INC. | $259.25 | 2019-2025 | |
| Allergan, INC. | $230.53 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $213.50 | 2019-2025 | Capvaxive, M-M-R II, Gardasil 9 |
| Amgen INC. | $188.33 | 2019-2025 | Repatha, Otezla, Otezla |
| Astellas Pharma US INC | $185.84 | 2019-2024 | Veozah |
| Abbott Laboratories | $131.82 | 2021-2025 | Freestyle Libre, Proclaim |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $111.75 | 2022 | |
| Dexcom, INC. | $100.83 | 2021-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $66.29 | 2022-2025 | |
| Exact Sciences Corporation | $62.78 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $50.60 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $50.40 | 2020 | |
| Inspire Medical Systems, INC. | $40.70 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $39.18 | 2024-2025 | Voquezna |
| Medtronic, INC. | $38.79 | 2025 | Symplicity G3, Inceptiv |
| Eisai INC. | $33.26 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.84 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $28.73 | 2019-2021 | |
| Olympus America INC. | $27.76 | 2023 | Spiration Valve System |
| Lundbeck LLC | $25.05 | 2023 | Vyepti |
| Ibsa Pharma INC. | $23.98 | 2024 | Flector, Licart, Tirosint |
| Althera Pharmaceuticals LLC | $23.49 | 2021 | |
| Seqirus USA INC | $22.11 | 2025 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $19.74 | 2019 | |
| Nevro Corp. | $18.69 | 2019 | |
| Si-Bone, INC. | $16.57 | 2019 | |
| Horizon Therapeutics Plc | $15.60 | 2020 | |
| Genentech USA, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.